Related Experiment Video
Updated: Mar 15, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Pediatric bronchiolitis disease severity is associated with immune checkpoint dysregulation
Mehmet Akif Dundar1,2, Serife Erdem3,4,5, Benhur Cetin6
1Department of Pediatric Intensive Care, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Insights
Pediatric bronchiolitis severity is linked to immune checkpoint molecule dysregulation. Increased CTLA-4 and TIM-3 expression in T cells suggests potential biomarkers for disease progression and targeted therapies.
Area of Science:
- Immunology
- Pediatric Medicine
- Respiratory Diseases
Background:
- Immune dysregulation is central to bronchiolitis pathogenesis.
- Understanding immune responses is key to managing pediatric respiratory infections.
Purpose of the Study:
- Investigate immune checkpoint molecules and regulatory cytokines in pediatric bronchiolitis.
- Correlate immune markers with disease severity.
Main Methods:
- Prospective cohort study of 151 pediatric patients (1 month-2 years).
- Assessed immune checkpoint molecules (CTLA-4, TIM-3, TIGIT, GARP) and cytokines (IL-2Rα, 4-1BB, TGF-β1, LAG-3, galectin-9).
- Utilized flow cytometry and ELISA on T cell subsets and plasma.
Main Results:
- Decreased CD4+ T cell levels with increased severity.
- Elevated Treg in mild cases, decreased in moderate/severe cases.
- Increased CTLA-4 and TIM-3 expression in moderate/severe groups; elevated soluble PD-1, TIM-3, LAG-3, TGF-β1, 4-1BB in severe cases.
Conclusions:
- Bronchiolitis severity correlates with immune checkpoint dysregulation and immunosuppression.
- Altered T cell subsets and increased CTLA-4/TIM-3 indicate potential biomarkers.
- Findings offer insights into immunopathogenesis and potential for risk stratification and targeted therapies.
Background:
Immune dysregulation plays a pivotal role in the pathogenesis of bronchiolitis. This study aimed to investigate the role of immune checkpoint molecules and regulatory cytokines in relation to disease severity.
Methods:
A prospective cohort of 151 pediatric patients aged 1 month to 2 years was enrolled and classified into control, mild, moderate, and severe bronchiolitis groups. Immune checkpoint molecules (CTLA-4, TIM-3, TIGIT, GARP) and cytokines (IL-2Rα, 4-1BB, TGF-β1, LAG-3, galectin-9) were evaluated in CD4 + FOXP3+ (Treg) and CD4 + FOXP3-T cells, and in plasma using flow cytometry and ELISA.
Results:
CD4+ T cell levels decreased with increasing disease severity. Treg frequencies were elevated in mild cases but decreased in moderate and severe cases. CTLA-4 and TIM-3 expression increased on both Treg and non-Treg CD4+ T cells in moderate and severe groups. Soluble PD-1, TIM-3, LAG-3, TGF-β1, and 4-1BB levels were significantly elevated in severe bronchiolitis.
Conclusion:
Disease severity in bronchiolitis is associated with immune checkpoint dysregulation and an immunosuppressive environment. The observed alterations in T cell subsets and increased expression of CTLA-4 and TIM-3 highlight the potential of these molecules as biomarkers of disease progression.
Impact:
This study demonstrates that the severity of pediatric bronchiolitis is associated with the dysregulation of immune checkpoint molecules. It adds novel insight into the immunopathogenesis of bronchiolitis by focusing on early immune biomarkers beyond conventional inflammatory parameters. These findings may support risk stratification and contribute to the development of targeted therapies in future pediatric bronchiolitis management.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Cycle: Exhalation
